Allogeneic stem cell transplantation in AML - immunosuppression with Rapamycin as alternative to calcineurin inhibitors

被引：0
|
作者：
Reibke, R. [1 ]
Franko, L. [1 ]
Tischer, J. [1 ]
Kolb, H-J [2 ]
机构：
[1] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
[2] Tech Univ Munich, Dept Internal Med 3, Munich, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [21] Calcineurin Inhibitors Replacement By Ruxolitinib As Graft Versus Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
    Zhao, Yanmin
    Huang, He
    BLOOD, 2019, 134
  • [22] Daclizumab as primary immunosuppression in liver transplantation to spare calcineurin inhibitors
    Heffron, TG
    Smallwood, GA
    Pillian, T
    Romero, R
    Davis, LP
    Stieber, AC
    Boyer, TD
    HEPATOLOGY, 1999, 30 (04) : 175A - 175A
  • [23] Calcineurin inhibitors-free immunosuppression in early renal transplantation
    Olea, T
    Jiménez, C
    Escuín, F
    de Miguel, AG
    Ros, S
    Sanz, A
    NEFROLOGIA, 2004, 24 : 11 - 15
  • [24] Rapamycin-induced proteinuria following allogeneic hematopoietic stem cell transplantation
    K Hochegger
    E Wurz
    D Nachbaur
    A R Rosenkranz
    J Clausen
    Bone Marrow Transplantation, 2009, 44 : 63 - 65
  • [25] Rapamycin-induced proteinuria following allogeneic hematopoietic stem cell transplantation
    Hochegger, K.
    Wurz, E.
    Nachbaur, D.
    Rosenkranz, A. R.
    Clausen, J.
    BONE MARROW TRANSPLANTATION, 2009, 44 (01) : 63 - 65
  • [26] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Evgenii Shumilov
    Inna Shakhanova
    Johanna Flach
    Nicole Schmidt
    Susanne Buerki
    Myriam Legros
    Marie-Noëlle Kronig
    Yishai Ofran
    Sabine Gerull
    Michael Medinger
    Behrouz Mansouri Taleghani
    Jakob Passweg
    Jörg Halter
    Ulrike Bacher
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 224 - 231
  • [27] Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
    Shumilov, Evgenii
    Shakhanova, Inna
    Flach, Johanna
    Schmidt, Nicole
    Buerki, Susanne
    Legros, Myriam
    Kronig, Marie-Noelle
    Ofran, Yishai
    Gerull, Sabine
    Medinger, Michael
    Taleghani, Behrouz Mansouri
    Passweg, Jakob
    Halter, Joerg
    Bacher, Ulrike
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 224 - 231
  • [28] Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
    Gupta, Vikas
    Gotlib, Jason
    Radich, Jerald P.
    Kroeger, Nicolaus M.
    Rondelli, Damiano
    Verstovsek, Srdan
    Deeg, H. Joachim
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1274 - 1281
  • [29] The hierarchy of alternative donors for allogeneic hematopoietic stem cell transplantation in poor risk Aml in CR1 revisited
    Versluis, J.
    Labopin, M.
    Ruggeri, A.
    Socie, G.
    Wu, D.
    Volin, L.
    Blaise, D.
    Milpied, N.
    Craddock, C.
    Yakoub-Agha, I.
    Maertens, J.
    Ljungman, P.
    Huynh, A.
    Michallet, M.
    Deconinck, E.
    Chevallier, P.
    Passweg, J.
    Ciceri, F.
    Mohty, M.
    Cornelissen, J.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S9 - S9
  • [30] The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes.
    Sohn, Sang Kyun
    Lee, Soo Jung
    Kim, Jong Gwang
    Chae, Yee Soo
    Kang, Byung Woog
    Moon, Joon Ho
    Baek, Jin Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345